Skip to main content
  • University of California San Francisco
  • UCSF Health
  • Search UCSF
  • About UCSF
  • Give to UCSF
facebook twitter youtube instagram
Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF homepage

Main navigation

  • About
    • Steering Committee
    • Director's Statement
    • Stem Cell Resources
  • Research
    • Reproductive
    • Neural
    • Blood
    • Cardiac & Vascular Biology
    • Epithelial
    • Musculoskeletal
    • Ophthalmology
    • Pancreas & Liver
  • Faculty
  • News & Events
    • News
    • Events
    • Stem Cell Seminar
    • Science Session
    • Promote News & Events
  • Support Us
    • Donate Today
    • Ways to Contribute
    • About the Broads
    • About the Dolbys
  • Contact
    • Center Information
    • Leadership
    • Administrative Staff
    • Boardroom Reservations
    • Student Internships
    • Subscribe

Breadcrumb

  1. Home
  2. Experimental and Molecular Therapeutics

Experimental and Molecular Therapeutics

Abstract 2608: Ibrutinib significantly improves survival in a human Burkitt lymphoma (BL) xenograft NSG mouse model: Ibrutinib may be a potential adjuvant agent in the treatment of BL.

Experimental and Molecular Therapeutics

Sanghoon Lee, Changhong Yin, Timmy O'Connell, Matthew Barth, Janet Ayello, Lauren Harrison, Carmella van de Ven, Rodney Miles, Paul Galardy, Stanton C. Goldman, Megan Lim, Michelle Hermiston, Linda McAllister-Lucas, Lisa G. Roth, Sherrie L. Perkins, Mitchell S. Cairo

Subscribe to Experimental and Molecular Therapeutics
  • Contact Us
  • Accessibility
  • Privacy Policy
  • Terms of Use
  • A-Z Website List

© 2025 The Regents of the University of California